Coping Strategies and Social Support for Transition Readiness Among Youth With Sickle Cell Disease - Top-Institutions - MDSpire

Coping Strategies and Social Support for Transition Readiness Among Youth With Sickle Cell Disease

  • By

  • Apoorva S. Iyengar

  • Tanisha Belton

  • Jack Chen

  • Tisheya Ward

  • Olivia Teng

  • Banu Aygun

  • Abena Appiah-Kubi

  • Nataly Apollonsky

  • Donna Boruchov

  • Biree Andemariam

  • Omar Niss

  • Lori E. Crosby

  • Lisa Schwartz

  • Lamia Barakat

  • Kim Smith-Whitley

  • Sophia Jan

  • Caren Steinway

  • July 13, 2026

Share

Top Institutions in Hematology

Brief introduction explaining scope and methodology.

  • #1

    The Children’s Hospital of Philadelphia
    The Children’s Hospital of Philadelphia

    Philadelphia, PA

    Key Differentiators

    • Pediatrics

  • #2

    St Christopher’s Hospital for Children
    St Christopher’s Hospital for Children

    Philadelphia, PA

    Key Differentiators

    • Pediatrics

  • #3

    Cincinnati Children’s Hospital and Medical Center
    Cincinnati Children’s Hospital and Medical Center

    Cincinnati, OH

    Key Differentiators

    • Pediatrics

  • #4

    Cohen Children’s Medical Center
    Cohen Children’s Medical Center

    New Hyde Park, NY

    Key Differentiators

    • Pediatrics

  • #5

    Connecticut Children’s Medical Center
    Connecticut Children’s Medical Center

    Hartford, CT

    Key Differentiators

    • Pediatrics

Original Source(s)

Coping Strategies and Social Support for Transition Readiness Among Youth With Sickle Cell Disease

  • by Apoorva S. Iyengar, Tanisha Belton, Jack Chen, Tisheya Ward, Olivia Teng, Banu Aygun, Abena Appiah-Kubi, Nataly Apollonsky, Donna Boruchov, Biree Andemariam, Omar Niss, Lori E. Crosby, Lisa Schwartz, Lamia Barakat, Kim Smith-Whitley, Sophia Jan, Caren Steinway

  • July 13, 2026

Related Content

One-carbon metabolism in cancer immunity: T-cell fitness, epigenetic programming, and therapeutic opportunities

Evaluation of pre-dilution combined with optical/fluorescent platelet counting for correcting pseudothrombocytopenia

Therapy-related myelodysplastic syndrome rapidly evolving to acute myeloid leukemia following CAR-T cell therapy in a patient with refractory diffuse large B-cell lymphoma: a case report